LEUKEMIA

Publications

  1. 2024
  2. Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

    Spanjaart, A. M., Ljungman, P., Tridello, G., Schwartz, J., Martinez-Cibrián, N., Barba, P., Kwon, M., Lopez-Corral, L., Martinez-Lopez, J., Ferra, C., Di Blasi, R., Ghesquieres, H., Mutsaers, P., Calkoen, F., Jak, M., van Doesum, J., Vermaat, J. S. P., van der Poel, M., Maertens, J., Gambella, M., Metafuni, E., Ciceri, F., Saccardi, R., Nicholson, E., Tholouli, E., Matthew, C., Potter, V., Bloor, A., Besley, C., Roddie, C., Wilson, K., Nagler, A., Campos, A., Petersen, S. L., Folber, F., Bader, P., Finke, J., Kroger, N., Knelange, N., de La Camara, R., Kersten, M. J. & Mielke, S., 09.2024, In: LEUKEMIA. 38, 9, p. 1985-1991 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study

    Kriegsmann, K., Ton, G. N. H. Q., Awwad, M. H. S., Benner, A., Bertsch, U., Besemer, B., Hänel, M., Fenk, R., Munder, M., Dürig, J., Blau, I. W., Huhn, S., Hose, D., Jauch, A., Mann, C., Weinhold, N., Scheid, C., Schroers, R., von Metzler, I., Schieferdecker, A., Thomalla, J., Reimer, P., Mahlberg, R., Graeven, U., Kremers, S., Martens, U. M., Kunz, C., Hensel, M., Seidel-Glätzer, A., Weisel, K. C., Salwender, H. J., Müller-Tidow, C., Raab, M. S., Goldschmidt, H., Mai, E. K. & Hundemer, M., 07.2024, In: LEUKEMIA. 38, 7, p. 1621-1625 5 p.

    Research output: SCORING: Contribution to journalLetterResearchpeer-review

  4. Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to pediatric-based GMALL protocols

    Neumann, M., Beder, T., Bastian, L., Hänzelmann, S., Bultmann, M., Wolgast, N., Hartmann, A., Trautmann, H., Ortiz-Tanchez, J., Schlee, C., Schroeder, M., Fransecky, L., Vosberg, S., Fiedler, W., Alakel, N., Heberling, L., Kondakci, M., Starck, M., Schwartz, S., Raffel, S., Müller-Tidow, C., Schneller, F., Reichle, A., Burmeister, T., Greif, P. A., Brüggemann, M., Gökbuget, N. & Baldus, C. D., 06.2024, In: LEUKEMIA. 38, 6, p. 1213-1222 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?

    Penack, O., Abouqateb, M., Peczynski, C., Boreland, W., Kröger, N., Stelljes, M., Gedde-Dahl, T., Blau, I. W., Schroeder, T., Salmenniemi, U., Kulagin, A., Peffault de Latour, R., Mielke, S., Zeiser, R., Moiseev, I., Schoemans, H., Koenecke, C. & Peric, Z., 05.2024, In: LEUKEMIA. 38, 5, p. 1156-1163 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries

    Lübke, J., Christen, D., Schwaab, J., Kaiser, A., Naumann, N., Shoumariyeh, K., Jentzsch, M., Sockel, K., Schaffrath, J., Ayuk, F. A., Stelljes, M., Hilgendorf, I., Sala, E., Kaivers, J., Schönland, S., Wittke, C., Hertenstein, B., Radsak, M., Kaiser, U., Brückl, V., Kröger, N., Brümmendorf, T. H., Hofmann, W-K., Klein, S., Jost, E., Reiter, A. & Panse, J., 04.2024, In: LEUKEMIA. 38, 4, p. 810-821 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: results from the EPICOVIDEHA survey

    Mai, E. K., Hielscher, T., Bertsch, U., Salwender, H. J., Zweegman, S., Raab, M. S., Munder, M., Pantani, L., Mancuso, K., Brossart, P., Beksac, M., Blau, I. W., Dürig, J., Besemer, B., Fenk, R., Reimer, P., van der Holt, B., Hänel, M., von Metzler, I., Graeven, U., Müller-Tidow, C., Boccadoro, M., Scheid, C., Dimopoulos, M. A., Hillengass, J., Weisel, K. C., Cavo, M., Sonneveld, P. & Goldschmidt, H., 03.2024, In: LEUKEMIA. 38, 3, p. 640-647 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. 2023
  9. Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M

    Gurnari, C., Gagelmann, N., Badbaran, A., Awada, H., Dima, D., Pagliuca, S., D'Aveni-Piney, M., Attardi, E., Voso, M. T., Cerretti, R., Wolschke, C., Rubio, M. T., Maciejewski, J. P. & Kröger, N., 03.2023, In: LEUKEMIA. 37, 3, p. 717-719 3 p.

    Research output: SCORING: Contribution to journalLetterResearchpeer-review

  10. Frequency and prognostic implications of KMT2A rearrangements in children with precursor B-cell lymphoma

    Au-Yeung, R. K. H., Padilla, L. A., Zimmermann, M., Reinke, S., Oschlies, I., Escherich, G., Woessmann, W., Burkhardt, B. & Klapper, W., 02.2023, In: LEUKEMIA. 37, 2, p. 488-491 4 p.

    Research output: SCORING: Contribution to journalLetterResearchpeer-review

  11. 2022
  12. Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape

    Greinix, H. T., Ayuk, F. & Zeiser, R., 11.2022, In: LEUKEMIA. 36, 11, p. 2558-2566 9 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  13. Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial

    Eichinger, A., Poetschger, U., Glogova, E., Bader, P., Basu, O., Beier, R., Burkhardt, B., Classen, C-F., Claviez, A., Corbacioglu, S., Deubzer, H. E., Greil, J., Gruhn, B., Güngör, T., Kafa, K., Kühl, J-S., Lang, P., Lange, B. S., Meisel, R., Müller, I., Sauer, M. G., Schlegel, P-G., Schulz, A., Stachel, D., Strahm, B., Wawer, A., Peters, C. & Albert, M. H., 11.2022, In: LEUKEMIA. 36, 11, p. 2567-2576 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia

    Möker, P., Zur Stadt, U., Zimmermann, M., Alawi, M., Mueller, S., Finger, J., Knörr, F., Riquelme, A., Oschlies, I., Klapper, W., Bradtke, J., Burkhardt, B., Woessmann, W. & Damm-Welk, C., 09.2022, In: LEUKEMIA. 36, 9, p. 2343-2346 4 p.

    Research output: SCORING: Contribution to journalLetterResearch

  15. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution

    Richter-Pechańska, P., Kunz, J. B., Rausch, T., Erarslan-Uysal, B., Bornhauser, B., Frismantas, V., Assenov, Y., Zimmermann, M., Happich, M., von Knebel-Doeberitz, C., von Neuhoff, N., Köhler, R., Stanulla, M., Schrappe, M., Cario, G., Escherich, G., Kirschner-Schwabe, R., Eckert, C., Avigad, S., Pfister, S. M., Muckenthaler, M. U., Bourquin, J-P., Korbel, J. O. & Kulozik, A. E., 07.2022, In: LEUKEMIA. 36, 7, p. 1759-1768 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma

    Mateos, M-V., Weisel, K., De Stefano, V., Goldschmidt, H., Delforge, M., Mohty, M., Cavo, M., Vij, R., Lindsey-Hill, J., Dytfeld, D., Angelucci, E., Perrot, A., Benjamin, R., van de Donk, N. W. C. J., Ocio, E. M., Scheid, C., Gay, F., Roeloffzen, W., Rodriguez-Otero, P., Broijl, A., Potamianou, A., Sakabedoyan, C., Semerjian, M., Keim, S., Strulev, V., Schecter, J. M., Vogel, M., Wapenaar, R., Nesheiwat, T., San-Miguel, J., Sonneveld, P., Einsele, H. & Moreau, P., 05.2022, In: LEUKEMIA. 36, 5, p. 1371-1376 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA

    Facon, T., Cook, G., Usmani, S. Z., Hulin, C., Kumar, S., Plesner, T., Touzeau, C., Bahlis, N. J., Basu, S., Nahi, H., Goldschmidt, H., Quach, H., Mohty, M., Venner, C. P., Weisel, K., Raje, N., Hebraud, B., Belhadj-Merzoug, K., Benboubker, L., Decaux, O., Manier, S., Caillot, D., Ukropec, J., Pei, H., Van Rampelbergh, R., Uhlar, C. M., Kobos, R. & Zweegman, S., 04.2022, In: LEUKEMIA. 36, 4, p. 1066-1077 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: interim analysis of the GMMG-CONCEPT trial

    Leypoldt, L. B., Besemer, B., Asemissen, A. M., Hänel, M., Blau, I. W., Görner, M., Ko, Y-D., Reinhardt, H. C., Staib, P., Mann, C., Lutz, R., Munder, M., Graeven, U., Peceny, R., Salwender, H., Jauch, A., Zago, M., Benner, A., Tichy, D., Bokemeyer, C., Goldschmidt, H. & Weisel, K. C., 03.2022, In: LEUKEMIA. 36, 3, p. 885-888 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  19. SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia

    Mellinghoff, S. C., Robrecht, S., Mayer, L., Weskamm, L. M., Dahlke, C., Gruell, H., Vanshylla, K., Schlösser, H. A., Thelen, M., Fink, A-M., Fischer, K., Klein, F., Addo, M. M., Eichhorst, B., Hallek, M. & Langerbeins, P., 02.2022, In: LEUKEMIA. 36, 2, p. 562-565 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  20. 2021
  21. Enhanced differentiation of functional human T cells in NSGW41 mice with tissue-specific expression of human interleukin-7

    Coppin, E., Sundarasetty, B. S., Rahmig, S., Blume, J., Verheyden, N. A., Bahlmann, F., Ravens, S., Schubert, U., Schmid, J., Ludwig, S., Geissler, K., Guntinas-Lichius, O., von Kaisenberg, C., Groten, T., Platz, A., Naumann, R., Ludwig, B., Prinz, I., Waskow, C. & Krueger, A., 12.2021, In: LEUKEMIA. 35, 12, p. 3561-3567 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT

    Kröger, N., Sbianchi, G., Sirait, T., Wolschke, C., Beelen, D., Passweg, J., Robin, M., Vrhovac, R., Helbig, G., Sockel, K., Conneally, E., Rubio, M. T., Beguin, Y., Finke, J., Bernasconi, P., Morozova, E., Clausen, J., von dem Borne, P., Schaap, N., Schroyens, W., Patriarca, F., Di Renzo, N., Yeğin, Z. A., Hayden, P., McLornan, D. & Yakoub-Agha, I., 12.2021, In: LEUKEMIA. 35, 12, p. 3551-3560 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

    Spanjaart, A. M., Ljungman, P., de La Camara, R., Tridello, G., Ortiz-Maldonado, V., Urbano-Ispizua, A., Barba, P., Kwon, M., Caballero, D., Sesques, P., Bachy, E., Di Blasi, R., Thieblemont, C., Calkoen, F., Mutsaers, P., Maertens, J., Giannoni, L., Nicholson, E., Collin, M., Vaz, C. P., Metafuni, E., Martinez-Lopez, J., Dignan, F. L., Ribera, J-M., Nagler, A., Folber, F., Sanderson, R., Bloor, A., Ciceri, F., Knelange, N., Ayuk, F., Kroger, N., Kersten, M. J. & Mielke, S., 12.2021, In: LEUKEMIA. 35, 12, p. 3585-3588 4 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  24. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey

    Ljungman, P., de la Camara, R., Mikulska, M., Tridello, G., Aguado, B., Zahrani, M. A., Apperley, J., Berceanu, A., Bofarull, R. M., Calbacho, M., Ciceri, F., Lopez-Corral, L., Crippa, C., Fox, M. L., Grassi, A., Jimenez, M-J., Demir, S. K., Kwon, M., Llamas, C. V., Lorenzo, J. L. L., Mielke, S., Orchard, K., Porras, R. P., Vallisa, D., Xhaard, A., Knelange, N. S., Cedillo, A., Kröger, N., Piñana, J. L. & Styczynski, J., 10.2021, In: LEUKEMIA. 35, 10, p. 2885-2894 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Distribution of major lymphocyte subsets and memory T-cell subpopulations in healthy adults employing GLP-conforming multicolor flow cytometry

    Schultze-Florey, C. R., Chukhno, E., Goudeva, L., Blasczyk, R., Ganser, A., Prinz, I., Förster, R., Koenecke, C. & Odak, I., 10.2021, In: LEUKEMIA. 35, 10, p. 3021-3025 5 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  26. Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study

    Boer, J. M., Valsecchi, M. G., Hormann, F. M., Antić, Ž., Zaliova, M., Schwab, C., Cazzaniga, G., Arfeuille, C., Cavé, H., Attarbaschi, A., Strehl, S., Escherich, G., Imamura, T., Ohki, K., Grüber, T. A., Sutton, R., Pastorczak, A., Lammens, T., Lambert, F., Li, C. K., Carrillo de Santa Pau, E., Hoffmann, S., Möricke, A., Harrison, C. J., Den Boer, M. L., De Lorenzo, P., Stam, R. W., Bergmann, A. K. & Pieters, R., 10.2021, In: LEUKEMIA. 35, 10, p. 2978-2982 5 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  27. Long-term follow-up of subcutaneous versus intravenous bortezomib during induction therapy for newly diagnosed multiple myeloma treated within the GMMG-MM5 Phase III Trial

    Salwender, H., Elmaagacli, A., Merz, M., Miah, K., Benner, A., Haenel, M., Jehn, C., Mai, E. K., Bertsch, U., Blau, I. W., Scheid, C., Hose, D., Seckinger, A., Jauch, A., Raab, M. S., Luntz, S. P., Besemer, B., Munder, M., Brossart, P., Fuhrmann, S., Lindemann, H-W., Weisel, K., Duerig, J. & Goldschmidt, H., 10.2021, In: LEUKEMIA. 35, 10, p. 3007-3011 5 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  28. Selective elimination of immunosuppressive T cells in patients with multiple myeloma

    Awwad, M. H. S., Mahmoud, A., Bruns, H., Echchannaoui, H., Kriegsmann, K., Lutz, R., Raab, M. S., Bertsch, U., Munder, M., Jauch, A., Weisel, K., Maier, B., Weinhold, N., Salwender, H. J., Eckstein, V., Hänel, M., Fenk, R., Dürig, J., Brors, B., Benner, A., Müller-Tidow, C., Goldschmidt, H. & Hundemer, M., 09.2021, In: LEUKEMIA. 35, 9, p. 2602-2615 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Efficacy and safety profile of deep responders to carfilzomib-based therapy: a subgroup analysis from ASPIRE and ENDEAVOR

    Weisel, K., Mateos, M-V., Gay, F., Delforge, M., Cook, G., Szabo, Z., Desgraz, R., DeCosta, L. & Moreau, P., 06.2021, In: LEUKEMIA. 35, 6, p. 1732-1744 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

    Dimopoulos, M., Weisel, K., Moreau, P., Anderson, L. D., White, D., San-Miguel, J., Sonneveld, P., Engelhardt, M., Jenner, M., Corso, A., Dürig, J., Pavic, M., Salomo, M., Casal, E., Srinivasan, S., Yu, X., Nguyen, T. V., Biyukov, T., Peluso, T. & Richardson, P., 06.2021, In: LEUKEMIA. 35, 6, p. 1722-1731 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li-Fraumeni syndrome

    Winter, G., Kirschner-Schwabe, R., Groeneveld-Krentz, S., Escherich, G., Möricke, A., von Stackelberg, A., Stanulla, M., Bailey, S., Richter, L., Steinemann, D., Ripperger, T., Escudero, A., Farah, R., Lohi, O., Wadt, K., Jongmans, M., van Engelen, N., Eckert, C. & Kratz, C. P., 05.2021, In: LEUKEMIA. 35, 5, p. 1475-1479 5 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  32. Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE

    Goldschmidt, H., Baertsch, M-A., Schlenzka, J., Becker, N., Habermehl, C., Hielscher, T., Raab, M-S., Hillengass, J., Sauer, S., Müller-Tidow, C., Luntz, S., Jauch, A., Hose, D., Seckinger, A., Brossart, P., Goerner, M., Klein, S., Schmidt-Hieber, M., Reimer, P., Graeven, U., Fenk, R., Haenel, M., Martin, H., Lindemann, H. W., Scheid, C., Nogai, A., Salwender, H., Noppeney, R., Besemer, B., Weisel, K. & German Myeloma Multicenter Group (GMMG), 04.2021, In: LEUKEMIA. 35, 4, p. 1134-1144 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2

    von Wenserski, L., Schultheiß, C., Bolz, S., Schliffke, S., Simnica, D., Willscher, E., Gerull, H., Wolters-Eisfeld, G., Riecken, K., Fehse, B., Altfeld, M., Nollau, P. & Binder, M., 04.2021, In: LEUKEMIA. 35, 4, p. 1073-1086 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age

    Mai, E. K., Miah, K., Bertsch, U., Dürig, J., Scheid, C., Weisel, K. C., Kunz, C., Munder, M., Lindemann, H-W., Merz, M., Hose, D., Jauch, A., Seckinger, A., Luntz, S., Sauer, S., Fuhrmann, S., Brossart, P., Elmaagacli, A., Goerner, M., Bernhard, H., Hoffmann, M., Raab, M. S., Blau, I. W., Hänel, M., Benner, A., Salwender, H. J., Goldschmidt, H. & German-speaking Myeloma Multicenter Group (GMMG), 03.2021, In: LEUKEMIA. 35, 3, p. 809-822 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Post-transplantation cyclophosphamide GvHD prophylaxis after hematopoietic stem cell transplantation from 9/10 or 10/10 HLA-matched unrelated donors for acute leukemia

    Lorentino, F., Labopin, M., Ciceri, F., Vago, L., Fleischhauer, K., Afanasyev, B., Kröger, N., Cornelissen, J. J., Lovira, M., Meijer, E., Vitek, A., Elmaagacli, A., Blaise, D., Ruggeri, A., Chabannon, C., Nagler, A., Mohty, M. & Acute Leukemia Working Party (ALWP) and Cellular Therapy and Immunobiology Working Party (CTIWP) of the European Society for Blood and Marrow Transplantation (EBMT), 02.2021, In: LEUKEMIA. 35, 2, p. 585-594 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma

    Reutter, K., Sandmann, S., Rohde, J., Müller, S., Wöste, M., Khanam, T., Michgehl, U., Klapper, W., Wößmann, W., Seggewiß, J., Lenz, G., Dugas, M. & Burkhardt, B., 02.2021, In: LEUKEMIA. 35, 2, p. 639-643 5 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  37. Second malignant neoplasms after treatment of non-Hodgkin's lymphoma-a retrospective multinational study of 189 children and adolescents

    Attarbaschi, A., Carraro, E., Ronceray, L., Andrés, M., Barzilai-Birenboim, S., Bomken, S., Brugières, L., Burkhardt, B., Ceppi, F., Chiang, A. K. S., Csoka, M., Fedorova, A., Jazbec, J., Kabickova, E., Loeffen, J., Mellgren, K., Miakova, N., Moser, O., Osumi, T., Pourtsidis, A., Rigaud, C., Uyttebroeck, A., Woessmann, W., Pillon, M. & European Intergroup for Childhood Non-Hodgkin’s Lymphoma (EICNHL) and the International Berlin-Frankfurt-Münster (i-BFM) Study Group, 02.2021, In: LEUKEMIA. 35, 2, p. 534-549 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation

    Hernández-Boluda, J. C., Pereira, A., Kröger, N., Beelen, D., Robin, M., Bornhäuser, M., Angelucci, E., Vitek, A., Blau, I. W., Niittyvuopio, R., Finke, J., Cornelissen, J. J., Passweg, J., Dreger, P., Petersen, E., Kanz, L., Sanz, J., Zuckerman, T., Zinger, N., Iacobelli, S., Hayden, P., Czerw, T., McLornan, D. & Yakoub-Agha, I., 01.2021, In: LEUKEMIA. 35, 1, p. 215-224 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network

    Ludwig, H., Boccadoro, M., Moreau, P., San-Miguel, J., Cavo, M., Pawlyn, C., Zweegman, S., Facon, T., Driessen, C., Hajek, R., Dimopoulos, M. A., Gay, F., Avet-Loiseau, H., Terpos, E., Zojer, N., Mohty, M., Mateos, M-V., Einsele, H., Delforge, M., Caers, J., Weisel, K., Jackson, G., Garderet, L., Engelhardt, M., van de Donk, N., Leleu, X., Goldschmidt, H., Beksac, M., Nijhof, I., Abildgaard, N., Bringhen, S. & Sonneveld, P., 01.2021, In: LEUKEMIA. 35, 1, p. 31-44 14 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  40. 2020
  41. Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma

    Goldschmidt, H., Dimopoulos, M. A., Rajkumar, S. V., Weisel, K. C., Moreau, P., Chng, W-J., Mikala, G., Cavo, M., Ramasamy, K., Suryanarayan, K., Teng, Z., Labotka, R. & Mateos, M. V., 11.2020, In: LEUKEMIA. 34, 11, p. 3019-3027 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Safety and efficacy of BAY1436032 in IDH1-mutant AML: phase I study results

    Heuser, M., Palmisiano, N., Mantzaris, I., Mims, A., DiNardo, C., Silverman, L. R., Wang, E. S., Fiedler, W., Baldus, C., Schwind, S., Pardee, T., Perl, A. E., Cai, C., Kaulfuss, S., Lagkadinou, E., Rentzsch, C., Wagner, M., Wilkinson, G., Wu, B., Jeffers, M., Genvresse, I. & Krämer, A., 11.2020, In: LEUKEMIA. 34, 11, p. 2903-2913 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Correction: High-risk additional chromosomal abnormalities at low blast counts herald death by CML

    Hehlmann, R., Voskanyan, A., Lauseker, M., Pfirrmann, M., Kalmanti, L., Rinaldetti, S., Kohlbrenner, K., Haferlach, C., Schlegelberger, B., Fabarius, A., Seifarth, W., Spieß, B., Wuchter, P., Krause, S., Kolb, H-J., Neubauer, A., Hossfeld, D. K., Nerl, C., Gratwohl, A., Baerlocher, G. M., Burchert, A., Brümmendorf, T. H., Hasford, J., Hochhaus, A., Saußele, S., Baccarani, M. & SAKK and the German CML Study Group, 10.2020, In: LEUKEMIA. 34, 10, p. 2823

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  44. Leukemia-induced dysfunctional TIM-3+CD4+ bone marrow T cells increase risk of relapse in pediatric B-precursor ALL patients

    Blaeschke, F., Willier, S., Stenger, D., Lepenies, M., Horstmann, M. A., Escherich, G., Zimmermann, M., Rojas Ringeling, F., Canzar, S., Kaeuferle, T., Rohlfs, M., Binder, V., Klein, C. & Feuchtinger, T., 10.2020, In: LEUKEMIA. 34, 10, p. 2607-2620 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma

    Waizenegger, J. S., Ben-Batalla, I., Weinhold, N., Meissner, T., Wroblewski, M., Janning, M., Riecken, K., Binder, M., Atanackovic, D., Taipaleenmaeki, H., Schewe, D., Sawall, S., Gensch, V., Cubas-Cordova, M., Seckinger, A., Atanackovic, D., Hesse, E., Kröger, N., Fehse, B., Hose, D., Klein, B., Raab, M. S., Pantel, K., Bokemeyer, C. & Loges, S., 09.2020, In: LEUKEMIA. 34, 9, p. 2542

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  46. Development of CAR-T cell therapies for multiple myeloma

    Gagelmann, N., Riecken, K., Wolschke, C., Berger, C., Ayuk, F. A., Fehse, B. & Kröger, N., 09.2020, In: LEUKEMIA. 34, 9, p. 2317-2332 16 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  47. Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials

    Gavriatopoulou, M., Chari, A., Chen, C., Bahlis, N., Vogl, D. T., Jakubowiak, A., Dingli, D., Cornell, R. F., Hofmeister, C. C., Siegel, D., Berdeja, J. G., Reece, D., White, D., Lentzsch, S., Gasparetto, C., Huff, C. A., Jagannath, S., Baz, R., Nooka, A. K., Richter, J., Abonour, R., Parker, T. L., Yee, A. J., Moreau, P., Lonial, S., Tuchman, S., Weisel, K. C., Mohty, M., Choquet, S., Unger, T. J., Li, K., Chai, Y., Li, L., Shah, J., Shacham, S., Kauffman, M. G. & Dimopoulos, M. A., 09.2020, In: LEUKEMIA. 34, 9, p. 2430-2440 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. High-risk additional chromosomal abnormalities at low blast counts herald death by CML

    Hehlmann, R., Voskanyan, A., Lauseker, M., Pfirrmann, M., Kalmanti, L., Rinaldetti, S., Kohlbrenner, K., Haferlach, C., Schlegelberger, B., Fabarius, A., Seifarth, W., Spieß, B., Wuchter, P., Krause, S., Kolb, H-J., Neubauer, A., Hossfeld, D. K., Nerl, C., Gratwohl, A., Baerlocher, G. M., Burchert, A., Brümmendorf, T. H., Hasford, J., Hochhaus, A., Saußele, S., Baccarani, M. & SAKK and the German CML Study Group, 08.2020, In: LEUKEMIA. 34, 8, p. 2074-2086 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

    Horne, G. A., Stobo, J., Kelly, C., Mukhopadhyay, A., Latif, A. L., Dixon-Hughes, J., McMahon, L., Cony-Makhoul, P., Byrne, J., Smith, G., Koschmieder, S., BrÜmmendorf, T. H., Schafhausen, P., Gallipoli, P., Thomson, F., Cong, W., Clark, R. E., Milojkovic, D., Helgason, G. V., Foroni, L., Nicolini, F. E., Holyoake, T. L. & Copland, M., 07.2020, In: LEUKEMIA. 34, 7, p. 1775-1786 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant

    Aziz, M. D., Shah, J., Kapoor, U., Dimopoulos, C., Anand, S., Augustine, A., Ayuk, F., Chaudhry, M., Chen, Y-B., Choe, H. K., Etra, A., Gergoudis, S., Hartwell, M. J., Hexner, E. O., Hogan, W. J., Kitko, C. L., Kowalyk, S., Kröger, N., Merli, P., Morales, G., Nakamura, R., Ordemann, R., Pulsipher, M. A., Qayed, M., Reshef, R., Rösler, W., Schechter, T., Schreiner, E., Srinagesh, H., Wölfl, M., Wudhikarn, K., Yanik, G., Young, R., Özbek, U., Ferrara, J. L. M. & Levine, J. E., 07.2020, In: LEUKEMIA. 34, 7, p. 1898-1906 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial

    Goldschmidt, H., Mai, E. K., Dürig, J., Scheid, C., Weisel, K. C., Kunz, C., Bertsch, U., Hielscher, T., Merz, M., Munder, M., Lindemann, H-W., Hügle-Dörr, B., Tichy, D., Giesen, N., Hose, D., Seckinger, A., Huhn, S., Luntz, S., Jauch, A., Elmaagacli, A., Rabold, B., Fuhrmann, S., Brossart, P., Goerner, M., Bernhard, H., Hoffmann, M., Hillengass, J., Raab, M. S., Blau, I. W., Hänel, M., Salwender, H. J. & German-speaking Myeloma Multicenter Group (GMMG), 07.2020, In: LEUKEMIA. 34, 7, p. 1853-1865 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. ATM activity in T cells is critical for immune surveillance of lymphoma in vivo

    Riabinska, A., Lehrmann, D., Jachimowicz, R. D., Knittel, G., Fritz, C., Schmitt, A., Geyer, A., Heneweer, C., Wittersheim, M., Frenzel, L. P., Torgovnick, A., Wiederstein, J. L., Wunderlich, C. M., Ortmann, M., Paillard, A., Wößmann, W., Borkhardt, A., Burdach, S., Hansmann, M-L., Rosenwald, A., Perner, S., Mall, G., Klapper, W., Merseburg, A., Krüger, M., Grüll, H., Persigehl, T., Wunderlich, F. T., Peifer, M., Utermöhlen, O., Büttner, R., Beleggia, F. & Reinhardt, H. C., 03.2020, In: LEUKEMIA. 34, 3, p. 771-786 16 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice

    Vorbach, S., Gründer, A., Zhou, F., Koellerer, C., Jutzi, J. S., Simoni, M., Riccetti, L., Valk, P. J., Sanders, M. A., Müller-Tidow, C., Nofer, J-R., Pahl, H. L. & Potì, F., 03.2020, In: LEUKEMIA. 34, 3, p. 721-734 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial

    Cicconi, L., Platzbecker, U., Avvisati, G., Paoloni, F., Thiede, C., Vignetti, M., Fazi, P., Ferrara, F., Divona, M., Albano, F., Efficace, F., Sborgia, M., Di Bona, E., Breccia, M., Borlenghi, E., Cairoli, R., Rambaldi, A., Melillo, L., La Nasa, G., Fiedler, W., Brossart, P., Hertenstein, B., Salih, H. R., Annibali, O., Wattad, M., Lubbert, M., Brandts, C. H., Hanel, M., Rollig, C., Schmitz, N., Link, H., Frairia, C., Fozza, C., Maria D'Arco, A., Di Renzo, N., Cortelezzi, A., Fabbiano, F., Dohner, K., Ganser, A., Dohner, H., Amadori, S., Mandelli, F., Voso, M. T., Ehninger, G., Schlenk, R. F. & Lo-Coco, F., 03.2020, In: LEUKEMIA. 34, 3, p. 914-918 5 p.

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

Previous 1 2 3 4 5 Next